Table 1.
Breast tumor clinicopathological characteristics
| Breast Cancer Clinicopathological Characteristics | Number of Patients N = 70 |
|---|---|
| Median Patient Age yrs (IQR) | 52 (48-64) |
| Median Tumor Size mm (IQR) | 25 (20-35) |
| Histologic Subtype | |
| Invasive Ductal | 59 |
| Invasive Lobular | 6 |
| Colloid/Mucinous | 2 |
| Tubular | 2 |
| Papillary | 1 |
| Intrinsic Subtype | |
| Luminal A (ER/PR+, HER2/neu-) | 38 |
| Luminal B (ER/PR+, HER2/neu+) | 7 |
| HER2 Overexpressing (ER-, PR-, HER2/neu+) | 10 |
| Triple-Negative (ER-,PR-,HER2/neu-) | 9 |
| Missing data | 6 |
| Grade | |
| 1 | 13 |
| 2 | 17 |
| 3 | 38 |
| Missing data | 2 |
| Nodal Status | |
| Node Negative | 46 |
| N1 | 8 |
| N2 | 11 |
| N3 | 5 |
| ER Status | |
| -ER Positive | 41 |
| -ER Negative | 29 |
| PR Status | |
| PR Positive | 41 |
| PR Negative | 27 |
| Missing data | 2 |
| HER2/neu Status | |
| HER2 Positive | 18 |
| HER2 Negative | 47 |
| Missing data | 5 |
| UICC Stage | |
| Stage 1 | 19 |
| Stage 2a | 28 |
| Stage 2b | 4 |
| Stage 3a | 9 |
| Stage 3b | 3 |
| Stage 3c | 5 |
| Stage 4 | 2 |